Jtc Share Discussion Threads

[kaos3] 13/12/2017 18:30

banks as the industry is through the centuries operating at a loss. when good times roll superb profits. when bad times - loses are communised to protect the public interest. pick the cycle. be aware of the interest rates cycle and fiat currency life span. etc

[kaos3] 13/12/2017 18:26

jtc last posted video recommends buying cheap US bank stocks as a play - it might be but for a limited period of time as there are long term risks coming from non financial part of humanity is what I am saying. banks could become partially obsolete in their present form. investing into bank stock is due to the leverage used like investing in a highly leveraged hedge fund

[freddie ferret] 13/12/2017 17:43

The future is not crypto, it is Bitcoin.

[jtcod] 13/12/2017 07:40

Did you intend that post for this thread kaos3?

[kaos3] 12/12/2017 18:41

I agree that banks are in a good shape and stock is priced favourably but:
+ banking profits are coming from all around but classic loan making
+ they thrive on regulation (populus hates it)
+ due to (there is enormous IF) the new tech and regulations and possible system reset most of their "protected" business could become obsolete in the present form

as W Buffett says - if it is complicated - too complicated, if it smells ....

[jtcod] 12/12/2017 18:27

I wonder how many pensions have invested in the growing crypto trend. It's perfect. Someone with no skin in the game makes a decision on behalf of other people who don't even know it's happening....and the authorities are not even overseeing the IPO's.

[jtcod] 12/12/2017 17:59

I bet just about every crooked executive that ever was is looking at crypto currencies right now and wondering how they can sell a tale. ?

[freddie ferret] 12/12/2017 16:28

Stigologist does not like Bitcoin it seems.

Anyway I stick by my view will 40 bag from here, will remain volatle for next ten years. Will then become the main method of exchange.
Countries that legislate against it in the short term will become less efficient than those that adopt it.

[jtcod] 12/12/2017 10:46

Earlier in the year Steve Eisman (one of the guys who made a fortune shorting the Mortage Based Securities market) did an interview. Eisman is a Bank Analyst. Anyway, I thought I would post it hear because he talks with simple common sense and some humility about the current industry, the crises and the aftermath.For those interestedhttps://m.youtube.com/watch?v=NJodqhzqPKQ

[the stigologist] 11/12/2017 15:59

AOR AorTech

a great prediction from just 1 week ago...

up 200% since then and it's just the start IMO

[the stigologist] 11/12/2017 15:49

AOR AorTech

This is a beautiful shareholder list.

Strong holders who understand the potential. Have held firm through all the bad times.

Very limited No. of Shares in Issue

AND

Very limited Free Float

[the stigologist] 11/12/2017 10:04

AOR

This makes for such good reading :-

'Multiples'!



Our licensees have generated considerable value by utilising Elast-Eon(TM). One example of this is a cardiovascular device that differs only from competing devices by having a thin Elast-Eon(TM) coating. This coating provides the device with superior properties and allows a sales price of many multiples of standard devices. The cost of materials and license fees, however, are less than 5% of the device's sales value.

The value added to licensees is not only greater than licence fees payable, but the value of the licence fees to our customers is significantly more than the market capitalisation of AorTech

The Board has conducted a thorough review of the Company's IP and where it fits into the medical device market, leading to the conclusion that there are a number of opportunities available to grow AorTech's business. A detailed strategic plan to allow AorTech to commercialise its platform technology is currently being considered and we will report to shareholders when the process is concluded.

We have the opportunity of putting past issues behind us and building on the core IP within the business. As part of this "fresh start", I am delighted to welcome Stockdale Securities as our new Nominated Adviser and broker and look forward to working with them to help AorTech reach its true potential.

[the stigologist] 11/12/2017 08:44

Aortech (AOR)

sp 22.5p
shares o/s 5.6m
mkt cap £1.2m

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510k's, CE Marks, Australian TGA and Japanese Ministry of Health approvals.

Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

Financials
Revenue $614k
Profit $55k
Cash $114k

Upside ?
1. Change in licensing strategy
"Our manufacturing licensee, Biomerics concluded a licence for Elast-Eon™ earlier this year together with a long term supply agreement. There are currently a number of companies evaluating Elast-Eon™ which if succesful may lead to other licences. Biomerics adopts a different approach to licensing to that which AorTech has historically pursued. AorTech signed a number of licences with very small/development companies long before products were ready for market launch. As a result, other than annual maintenance fees, the revenues from those licences depended upon future product launches. By contrast, Biomerics is focussed on volume supply and near term success."

2.Additional licensing opportunities
Some historic licences signed by the Company have not generated value for AorTech and have only resulted in the Elast-Eon™ material not being exploited in the field of the licence. An example of this was the licence for breast implants signed in 2011. Since that time, AorTech's technology has not been incorporated into any new device nor generated any revenue for AorTech despite maintaining an IP portfolio in this arena. Your Board still believes there to be substantial benefits in utilising Elast-Eon™ technology in cosmetic and reconstructive surgery and as a result recently terminated this licence in order to pursue other opportunities in the field.

Outlook/Conclusion (from August 15th Final Results RNS)

"A new revenue-generating licence has been signed and enquiries have increased markedly. We have taken back control of our breast implant IP and are actively pursuing opportunities to exploit this alongside our other intellectual property, including heart valves and polymers."



-------------------------------

Interesting stakebuilding.

Former CEO who resigned in Oct 2016 went above 10% holding in Sept 2017

Litigation

They were suing another former CEO but looks like settlement on that soon. Just drawing a line under it should be positive.


---------------------------------

[mount teide] 09/12/2017 11:46

Bitcoin - Economist Jim Rickards sums the the inane mania around the cryptocurrency very well.

Gold versus bitcoin — intrinsic value is meaningless for both but the bitcoin prices aren't real.

[jtcod] 08/12/2017 18:14

FreddieIt seems pretty obvious that Bitcoin's value has been significantly enhanced over the years by its unique status as a money laundering utopia. That status seems to be in jeopardy now. Even if there is a future for bitcoin as you say, it is likely to be a rocky transition period I think.

[chestnuts] 08/12/2017 08:04

maxk
Maybe thats the idea is to get all the drug money into bitcoins then sink it.

[chestnuts] 08/12/2017 08:04

maxk
Maybe thats the idea is to get all the drug money into bitcoins then sink it.

[maxk] 07/12/2017 23:46

$40k of what? That's lot of hot air/drug money.

[jtcod] 07/12/2017 23:10

Haha bootie. Anything is possible I guess but I suspect it will end in tears.

[bootie64] 07/12/2017 22:41

JTC,
I am beginning to believe the prediction made by Michael Novogratz may prove correct, with some sharp drops in between to add in the fun factor :)

"Bitcoin could be at $40,000 at the end of 2018. It easily could," Michael Novogratz says on CNBC's "Fast Money."


Also, whilst waiting to short Bitcoin you could always invest in the CryptoKitties game, which lets players trade digital kittens on the ethereum blockchain.







One Kitten was apparently first traded for over $4,000 on Dec. 2. Two days later, it was sold on for over $32,000. Yesterday, a user paid about $63,000 for it, and it’s now one of the the most expensive cats for sale in that user’s stable. It’s on offer for 240.12 ether, or about $106,000 at current prices.

:)

[jtcod] 07/12/2017 17:48

Went on to cross $16,000 today.

[freddie ferret] 07/12/2017 17:44

Rubbish.
Bitcoin is not an investment but THE new currency